Exploring Effects of Weight Loss on Ductal Carcinoma In Situ

探索减肥对导管原位癌的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): Obesity is a known risk factor for invasive breast cancers that occur post-menopause. Obese women also die twice as frequently from breast cancer than those of normal weight. Numerous preclinical studies show the benefits of caloric restriction on cancer progression in animals - but, will similar effects be seen in humans? In response to a call for translational studies that will identify biological/biobehavioral pathways through which weight loss may affect cancer prognosis (PAR-12-229), we propose a pilot study that builds on our success of pre-surgical interventions to answer the research question, "does negative energy balance with concomitant weight loss invoke anti-cancer effects on tumor biology and the host environment?" We will randomly assign 40 overweight or obese postmenopausal women diagnosed with ductal carcinoma in situ (DCIS) (a precursor to invasive cancer) who elect mastectomy or lumpectomy to 1-of-2 study arms: 1) an Attention Control Group that receives instruction on dietary approaches to correct nutritional deficiencies and progressive resistance training (PRT) that targets the arm ipsilateral to the affected breast; or 2 an Experimental Group that will receive PRT and guidance to correct nutritional deficiencies plus an intensive intervention to promote a 1.5-2 pound/week weight loss through diet, exercise, and behavior modification. This study will explore and contrast changes in body mass index (BMI) observed from enrollment to the time of surgery in the experimental vs. attention control arms, and also monitor changes in energy intake and physical activity. These changes will be studied in relation to the following endpoints: a) changes in select circulating biomarkers and gene expression related to cancer progression, hormonal status, inflammation and other energy-related factors; b) rates of tumor proliferation and apoptosis; c) tumor markers, e.g., insulin receptor, VEGF, AKT, NFkB, and phosphoproteins associated with the Convergence of Hormones, Inflammation and Energy-Rated Factors (CHIEF) pathway; and d) functional and health-related outcomes. Because both tumor tissue and blood will be examined from pre-to-post-intervention, this study will provide exciting new data that can elucidate pathways by which energy balance affects breast cancer progression from a non-invasive to an invasive state. Although longer term weight loss is recommended for overweight and obese breast cancer survivors, it is not known whether placing the body in a state of negative energy balance will have a favorable impact on the tumor. If beneficial changes in tumor biology and the host environment occur with short-term, pre-surgical weight loss, this study provides proof of concept that weight loss may offer an acceptable and complementary treatment option that could be combined with active surveillance for longer term management. Thus, the research that is proposed will not only increase our understanding of the impact of negative energy balance on tumor biology, but could change the standard of care and offer a more conservative treatment option for the 50,000 American women who are diagnosed with DCIS each year.
描述(由申请人提供):肥胖是侵入性乳腺癌的已知危险因素。肥胖的妇女也死于乳腺癌的频率是正常体重的两倍。许多临床前研究表明,热量限制对动物癌症进展的好处 - 但是,在人类中会看到类似的影响吗? In response to a call for translational studies that will identify biological/biobehavioral pathways through which weight loss may affect cancer prognosis (PAR-12-229), we propose a pilot study that builds on our success of pre-surgical interventions to answer the research question, "does negative energy balance with concomitant weight loss invoke anti-cancer effects on tumor biology and the host environment?" We will randomly assign 40 overweight or obese postmenopausal women diagnosed with ductal carcinoma in situ (DCIS) (a precursor to invasive cancer) who elect mastectomy or lumpectomy to 1-of-2 study arms: 1) an Attention Control Group that receives instruction on dietary approaches to correct nutritional deficiencies and progressive resistance training (PRT) that targets the arm ipsilateral to the affected 胸部;或2一个实验组,将获得PRT和指导,以纠正营养缺乏症,并采取强化干预措施,以通过饮食,运动和行为修改来促进1.5-2磅/周的体重减轻。这项研究将探索和对比度的变化体重指数(BMI)从入学到实验与注意力控制臂的手术时间观察到的,并监测能量摄入和体育活动的变化。这些变化将与以下终点有关:a)与癌症进展,荷尔蒙状态,炎症和其他能量相关因素有关的选择循环生物标志物和基因表达的变化; b)肿瘤增殖和凋亡率; c)肿瘤标记,例如胰岛素受体,VEGF,AKT,NFKB和磷蛋白与激素,炎症和能量评分因子(主要)途径相关的磷酸蛋白; d)功能和健康相关的结果。由于肿瘤组织和血液都将从预干预前进行检查,因此这项研究将提供令人兴奋的新数据,这些数据可以阐明能量平衡影响从非侵入性到侵入性状态的乳腺癌进展的途径。尽管建议对超重和肥胖的乳腺癌幸存者进行长期体重减轻,但尚不知道将身体处于负能量平衡状态是否会对肿瘤产生有利的影响。如果肿瘤生物学和宿主环境的有益变化发生在短期,手术前的体重减轻,这项研究提供了概念证明,即减肥可能会提供可接受的补充治疗方案,可以将其与长期管理的主动监视结合使用。因此,提出的研究不仅会增加我们对负能量平衡对肿瘤生物学的影响的理解,而且可以改变护理标准,并为每年被诊断出患有DCI的50,000名美国女性提供更保守的治疗选择。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wendy Demark-Wahnefried其他文献

Wendy Demark-Wahnefried的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wendy Demark-Wahnefried', 18)}}的其他基金

Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)
基于互联网的生活方式干预,消除前列腺癌幸存者的肥胖虚弱 (iLIVE)
  • 批准号:
    10678740
  • 财政年份:
    2023
  • 资助金额:
    $ 15.99万
  • 项目类别:
Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
适应多种行为有效改善 (AMPLIFI) 癌症幸存者健康的干预措施
  • 批准号:
    10318887
  • 财政年份:
    2021
  • 资助金额:
    $ 15.99万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10247785
  • 财政年份:
    2018
  • 资助金额:
    $ 15.99万
  • 项目类别:
Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
适应多种行为有效改善 (AMPLIFI) 癌症幸存者健康的干预措施
  • 批准号:
    10247730
  • 财政年份:
    2018
  • 资助金额:
    $ 15.99万
  • 项目类别:
Project 1: RENEWeb: Reaching-out to ENhance diet and Weight Control via the Web in Cancer Survivors
项目 1:RENEWeb:通过网络加强癌症幸存者的饮食和体重控制
  • 批准号:
    10247779
  • 财政年份:
    2018
  • 资助金额:
    $ 15.99万
  • 项目类别:
Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
适应多种行为有效改善 (AMPLIFI) 癌症幸存者健康的干预措施
  • 批准号:
    9581203
  • 财政年份:
    2018
  • 资助金额:
    $ 15.99万
  • 项目类别:
Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
适应多种行为有效改善 (AMPLIFI) 癌症幸存者健康的干预措施
  • 批准号:
    10679027
  • 财政年份:
    2018
  • 资助金额:
    $ 15.99万
  • 项目类别:
Harvest for Health in Older Cancer Survivors
老年癌症幸存者的健康收获
  • 批准号:
    10197801
  • 财政年份:
    2016
  • 资助金额:
    $ 15.99万
  • 项目类别:
Vegetable garden feasibility trial to promote function in older cancer survivors
菜园可行性试验促进老年癌症幸存者的功能
  • 批准号:
    8619527
  • 财政年份:
    2014
  • 资助金额:
    $ 15.99万
  • 项目类别:
Exploring Effects of Weight Loss on Ductal Carcinoma In Situ
探索减肥对导管原位癌的影响
  • 批准号:
    8827301
  • 财政年份:
    2014
  • 资助金额:
    $ 15.99万
  • 项目类别:

相似国自然基金

坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    45 万元
  • 项目类别:
    面上项目
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
  • 批准号:
    72272131
  • 批准年份:
    2022
  • 资助金额:
    45.00 万元
  • 项目类别:
    面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
  • 批准号:
    72162025
  • 批准年份:
    2021
  • 资助金额:
    29 万元
  • 项目类别:
    地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
  • 批准号:
    32100850
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients
炎症性肠病患者预防静脉血栓栓塞的抗凝剂使用、安全性和有效性
  • 批准号:
    10887842
  • 财政年份:
    2023
  • 资助金额:
    $ 15.99万
  • 项目类别:
A Randomized Pilot and Feasibility Study of a cultuRE-Directed approach to Urinary traCT Infection symptoms in older womeN: a mixed methods evaluation - the REDUCTION trial
针对老年女性尿路感染症状的文化导向方法的随机试验和可行性研究:混合方法评估 - REDUCTION 试验
  • 批准号:
    10586250
  • 财政年份:
    2023
  • 资助金额:
    $ 15.99万
  • 项目类别:
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
  • 批准号:
    10824878
  • 财政年份:
    2023
  • 资助金额:
    $ 15.99万
  • 项目类别:
Mechanisms of Immune Dysfunction in Oral Post-Acute Sequelae of Covid-19
Covid-19口腔急性后遗症中免疫功能障碍的机制
  • 批准号:
    10892624
  • 财政年份:
    2023
  • 资助金额:
    $ 15.99万
  • 项目类别:
Unraveling the mechanisms of a novel music intervention for physical activity promotion in older adults
揭示新型音乐干预促进老年人身体活动的机制
  • 批准号:
    10766983
  • 财政年份:
    2023
  • 资助金额:
    $ 15.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了